Based on 16 analysts giving stock ratings to Hims & Hers Health Inc in the past month.
In the current month, HIMS has received 4 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. HIMS average Analyst price target in the last month is 31.533.
Based on analysts' estimates, HIMS EPS is projected to reach 0.064 in FY2026Q3, following reported EPS of -0.372 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.37, while Hims & Hers Health IncHIMS's earnings per share (EPS) for the previous quarter was USD -0.40. EPS for the next quarter is expected at USD 0.06.